Share Price and Basic Stock Data
Last Updated: November 4, 2025, 3:51 pm
| PEG Ratio | 2.18 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Bombay Super Hybrid Seeds Ltd, operating in the agricultural products sector, reported a market capitalization of ₹1,304 Cr with its stock price standing at ₹124. The company’s revenue growth is notable, with sales increasing from ₹191 Cr in FY 2022 to ₹228 Cr in FY 2023, and expected to reach ₹256 Cr in FY 2024. The trailing twelve months (TTM) revenue stood at ₹355 Cr, indicating a robust growth trajectory. Quarterly sales figures display fluctuations, with a significant rise to ₹157 Cr in Jun 2024 from ₹117 Cr in Jun 2023, showcasing seasonal demand variations. The company’s operational efficiency is highlighted by a consistent increase in revenue, although some quarters like Sep 2023 reported a drop to ₹34 Cr. The average sales growth over the past few years suggests a solid market position, likely benefiting from the increasing demand for hybrid seeds in India, which is projected to grow as the agricultural sector modernizes.
Profitability and Efficiency Metrics
Bombay Super Hybrid Seeds Ltd has demonstrated commendable profitability metrics, with a reported net profit of ₹28 Cr in FY 2023, rising to ₹22 Cr in FY 2024. The operating profit margin (OPM) stood at 10%, reflecting the company’s ability to maintain profitability despite rising costs. The company’s return on equity (ROE) was recorded at 28.8%, indicating effective utilization of shareholder funds. Additionally, the interest coverage ratio (ICR) was a healthy 5.78x, suggesting that the company can comfortably meet its interest obligations. However, the cash conversion cycle (CCC) of 335 days raises concerns as it indicates prolonged inventory holding and receivables collection periods, potentially impacting liquidity. Overall, while profitability metrics are strong, efficiency improvements in inventory and receivables management remain critical for sustained performance.
Balance Sheet Strength and Financial Ratios
The balance sheet of Bombay Super Hybrid Seeds Ltd reflects a solid financial structure with total assets of ₹222 Cr and total liabilities of ₹222 Cr as of FY 2025. The company reported reserves of ₹94 Cr against borrowings of ₹92 Cr, indicating a balanced approach to financing and growth. The debt-to-equity ratio stood at 0.88, suggesting a moderate leverage level compared to industry norms. Furthermore, the price-to-book value (P/BV) ratio at 12.12x indicates that the stock may be trading at a premium compared to its book value, reflecting investor expectations for future growth. The return on capital employed (ROCE) was noted at 21.2%, which is above average for the agriculture sector, demonstrating efficient capital utilization. However, the company must address its reliance on external borrowings to ensure long-term financial stability.
Shareholding Pattern and Investor Confidence
Promoter holding in Bombay Super Hybrid Seeds Ltd remained stable at 73.85% as of Mar 2025, indicating strong insider confidence. The absence of foreign institutional investors (FIIs) reflects a potential area for growth in attracting international capital. The public shareholding stood at 26.15%, which is relatively high, suggesting a broad base of retail investors. The number of shareholders increased from 17,393, showing growing interest in the company’s equity. However, the lack of institutional investments could limit stock liquidity and market perception. The consistent promoter holding is a positive signal of confidence in the company’s long-term strategy, but the lack of diverse institutional backing may pose risks in terms of volatility during market fluctuations.
Outlook, Risks, and Final Insight
The outlook for Bombay Super Hybrid Seeds Ltd appears positive, driven by increasing demand for hybrid seeds amid agricultural advancements. The company’s strong profitability metrics and solid balance sheet provide a robust foundation for growth. However, risks include the high cash conversion cycle, which could impact liquidity, and the lack of institutional investor support, which may affect stock performance. Additionally, any fluctuations in agricultural commodity prices or changes in regulatory policies could pose challenges. To mitigate these risks, the company should focus on improving operational efficiencies and enhancing investor relations to attract institutional interest. Overall, while the company is well-positioned for growth, addressing these risks will be crucial for sustaining its positive trajectory.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Bombay Super Hybrid Seeds Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| GRM Overseas Ltd | 2,670 Cr. | 435 | 435/176 | 52.1 | 65.3 | 0.00 % | 12.1 % | 14.6 % | 2.00 |
| Freshtrop Fruits Ltd | 122 Cr. | 153 | 175/105 | 141 | 0.00 % | 6.12 % | 5.36 % | 10.0 | |
| City Crops Agro Ltd | 32.6 Cr. | 20.0 | 30.4/17.0 | 13.2 | 19.4 | 0.00 % | 8.46 % | 8.14 % | 10.0 |
| Chamanlal Setia Exports Ltd | 1,333 Cr. | 268 | 447/243 | 13.1 | 147 | 0.93 % | 16.7 % | 14.2 % | 2.00 |
| Mangalam Global Enterprise Ltd | 475 Cr. | 14.4 | 18.5/10.6 | 18.2 | 6.86 | 0.07 % | 16.8 % | 14.6 % | 1.00 |
| Industry Average | 3,490.91 Cr | 271.48 | 27.51 | 101.55 | 0.32% | 11.71% | 12.10% | 4.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 102 | 21 | 69 | 36 | 117 | 34 | 76 | 30 | 157 | 28 | 128 | 46 | 153 |
| Expenses | 93 | 20 | 61 | 32 | 104 | 31 | 67 | 27 | 143 | 25 | 118 | 40 | 138 |
| Operating Profit | 9 | 1 | 8 | 3 | 13 | 3 | 9 | 4 | 14 | 3 | 10 | 6 | 15 |
| OPM % | 9% | 7% | 12% | 9% | 11% | 9% | 12% | 12% | 9% | 11% | 8% | 13% | 10% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 0 |
| Interest | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 2 | 2 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 8 | 1 | 7 | 2 | 11 | 2 | 8 | 3 | 12 | 2 | 9 | 5 | 13 |
| Tax % | 6% | 10% | 6% | 3% | 5% | 10% | 14% | -21% | 7% | 15% | 1% | 8% | 7% |
| Net Profit | 7 | 1 | 7 | 2 | 11 | 2 | 7 | 3 | 11 | 2 | 9 | 4 | 12 |
| EPS in Rs | 0.70 | 0.08 | 0.63 | 0.18 | 1.01 | 0.15 | 0.66 | 0.30 | 1.06 | 0.20 | 0.86 | 0.40 | 1.17 |
Last Updated: August 1, 2025, 11:05 pm
Below is a detailed analysis of the quarterly data for Bombay Super Hybrid Seeds Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 153.00 Cr.. The value appears strong and on an upward trend. It has increased from 46.00 Cr. (Mar 2025) to 153.00 Cr., marking an increase of 107.00 Cr..
- For Expenses, as of Jun 2025, the value is 138.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 40.00 Cr. (Mar 2025) to 138.00 Cr., marking an increase of 98.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 15.00 Cr.. The value appears strong and on an upward trend. It has increased from 6.00 Cr. (Mar 2025) to 15.00 Cr., marking an increase of 9.00 Cr..
- For OPM %, as of Jun 2025, the value is 10.00%. The value appears to be declining and may need further review. It has decreased from 13.00% (Mar 2025) to 10.00%, marking a decrease of 3.00%.
- For Other Income, as of Jun 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1.00 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 1.00 Cr..
- For Interest, as of Jun 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 2.00 Cr..
- For Depreciation, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 13.00 Cr.. The value appears strong and on an upward trend. It has increased from 5.00 Cr. (Mar 2025) to 13.00 Cr., marking an increase of 8.00 Cr..
- For Tax %, as of Jun 2025, the value is 7.00%. The value appears to be improving (decreasing) as expected. It has decreased from 8.00% (Mar 2025) to 7.00%, marking a decrease of 1.00%.
- For Net Profit, as of Jun 2025, the value is 12.00 Cr.. The value appears strong and on an upward trend. It has increased from 4.00 Cr. (Mar 2025) to 12.00 Cr., marking an increase of 8.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 1.17. The value appears strong and on an upward trend. It has increased from 0.40 (Mar 2025) to 1.17, marking an increase of 0.77.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 5:34 am
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 31 | 63 | 110 | 82 | 75 | 103 | 171 | 191 | 228 | 256 | 358 | 355 |
| Expenses | 30 | 62 | 108 | 79 | 70 | 97 | 162 | 178 | 206 | 228 | 325 | 320 |
| Operating Profit | 1 | 1 | 1 | 3 | 4 | 6 | 9 | 14 | 22 | 28 | 33 | 35 |
| OPM % | 3% | 2% | 1% | 4% | 6% | 6% | 5% | 7% | 9% | 11% | 9% | 10% |
| Other Income | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 3 | 3 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 5 | 6 | 7 |
| Depreciation | 0 | 0 | 0 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | 0 | 0 | 1 | 2 | 3 | 3 | 6 | 11 | 18 | 24 | 28 | 29 |
| Tax % | 62% | 37% | 34% | 35% | 26% | 23% | 5% | 5% | 6% | 6% | 6% | |
| Net Profit | 0 | 0 | 1 | 1 | 2 | 3 | 6 | 10 | 17 | 22 | 26 | 28 |
| EPS in Rs | 0.01 | 0.05 | 0.16 | 0.15 | 0.20 | 0.25 | 0.55 | 1.00 | 1.60 | 2.12 | 2.52 | 2.63 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 0.00% | 100.00% | 50.00% | 100.00% | 66.67% | 70.00% | 29.41% | 18.18% |
| Change in YoY Net Profit Growth (%) | 0.00% | 100.00% | -50.00% | 50.00% | -33.33% | 3.33% | -40.59% | -11.23% |
Bombay Super Hybrid Seeds Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 8 years from 2017-2018 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 28% |
| 5 Years: | 28% |
| 3 Years: | 23% |
| TTM: | 20% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 91% |
| 5 Years: | 58% |
| 3 Years: | 36% |
| TTM: | 21% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 71% |
| 3 Years: | 37% |
| 1 Year: | -26% |
| Return on Equity | |
|---|---|
| 10 Years: | 28% |
| 5 Years: | 31% |
| 3 Years: | 32% |
| Last Year: | 29% |
Last Updated: September 5, 2025, 1:15 am
Balance Sheet
Last Updated: June 16, 2025, 12:21 pm
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 2 | 3 | 3 | 5 | 7 | 8 | 10 | 10 | 10 | 10 | 10 |
| Reserves | 0 | 0 | 1 | 3 | 14 | 15 | 18 | 29 | 46 | 68 | 94 |
| Borrowings | 6 | 7 | 12 | 16 | 13 | 16 | 30 | 39 | 53 | 48 | 92 |
| Other Liabilities | 1 | 4 | 4 | 7 | 4 | 8 | 13 | 19 | 24 | 36 | 25 |
| Total Liabilities | 8 | 15 | 20 | 31 | 38 | 47 | 73 | 98 | 133 | 162 | 222 |
| Fixed Assets | 2 | 3 | 5 | 4 | 9 | 9 | 8 | 7 | 9 | 7 | 9 |
| CWIP | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 7 | 12 | 15 | 24 | 29 | 38 | 64 | 91 | 124 | 155 | 213 |
| Total Assets | 8 | 15 | 20 | 31 | 38 | 47 | 73 | 98 | 133 | 162 | 222 |
Below is a detailed analysis of the balance sheet data for Bombay Super Hybrid Seeds Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 10.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 10.00 Cr..
- For Reserves, as of Mar 2025, the value is 94.00 Cr.. The value appears strong and on an upward trend. It has increased from 68.00 Cr. (Mar 2024) to 94.00 Cr., marking an increase of 26.00 Cr..
- For Borrowings, as of Mar 2025, the value is 92.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 48.00 Cr. (Mar 2024) to 92.00 Cr., marking an increase of 44.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 25.00 Cr.. The value appears to be improving (decreasing). It has decreased from 36.00 Cr. (Mar 2024) to 25.00 Cr., marking a decrease of 11.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 222.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 162.00 Cr. (Mar 2024) to 222.00 Cr., marking an increase of 60.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 9.00 Cr.. The value appears strong and on an upward trend. It has increased from 7.00 Cr. (Mar 2024) to 9.00 Cr., marking an increase of 2.00 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Mar 2025, the value is 213.00 Cr.. The value appears strong and on an upward trend. It has increased from 155.00 Cr. (Mar 2024) to 213.00 Cr., marking an increase of 58.00 Cr..
- For Total Assets, as of Mar 2025, the value is 222.00 Cr.. The value appears strong and on an upward trend. It has increased from 162.00 Cr. (Mar 2024) to 222.00 Cr., marking an increase of 60.00 Cr..
Notably, the Reserves (94.00 Cr.) exceed the Borrowings (92.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -5.00 | -6.00 | -11.00 | -13.00 | -9.00 | -10.00 | -21.00 | -25.00 | -31.00 | -20.00 | -59.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 17 | 15 | 12 | 19 | 15 | 25 | 16 | 31 | 14 | 14 | 7 |
| Inventory Days | 55 | 50 | 30 | 71 | 143 | 121 | 169 | 281 | 497 | 406 | 349 |
| Days Payable | 3 | 12 | 8 | 13 | 5 | 6 | 7 | 30 | 51 | 27 | 22 |
| Cash Conversion Cycle | 70 | 52 | 34 | 76 | 152 | 140 | 179 | 282 | 460 | 393 | 335 |
| Working Capital Days | 12 | 11 | 11 | 35 | 69 | 61 | 39 | 63 | 77 | 102 | 98 |
| ROCE % | 10% | 15% | 14% | 13% | 13% | 15% | 19% | 22% | 24% | 21% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 2.52 | 2.10 | 1.61 | 10.06 | 5.33 |
| Diluted EPS (Rs.) | 2.52 | 2.10 | 1.61 | 10.06 | 5.33 |
| Cash EPS (Rs.) | 2.64 | 2.25 | 1.73 | 11.26 | 7.12 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 9.98 | 7.46 | 5.37 | 37.63 | 27.57 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 9.98 | 7.46 | 5.37 | 37.63 | 27.57 |
| Revenue From Operations / Share (Rs.) | 34.19 | 24.48 | 21.72 | 184.68 | 163.28 |
| PBDIT / Share (Rs.) | 3.38 | 2.81 | 2.12 | 13.56 | 8.66 |
| PBIT / Share (Rs.) | 3.26 | 2.68 | 1.99 | 12.31 | 7.07 |
| PBT / Share (Rs.) | 2.67 | 2.24 | 1.70 | 10.51 | 5.82 |
| Net Profit / Share (Rs.) | 2.52 | 2.12 | 1.60 | 10.01 | 5.53 |
| PBDIT Margin (%) | 9.89 | 11.46 | 9.74 | 7.34 | 5.30 |
| PBIT Margin (%) | 9.53 | 10.93 | 9.15 | 6.66 | 4.32 |
| PBT Margin (%) | 7.82 | 9.15 | 7.82 | 5.68 | 3.56 |
| Net Profit Margin (%) | 7.36 | 8.64 | 7.36 | 5.41 | 3.38 |
| Return on Networth / Equity (%) | 25.22 | 28.38 | 29.78 | 26.59 | 20.04 |
| Return on Capital Employeed (%) | 32.34 | 35.32 | 35.58 | 31.46 | 23.00 |
| Return On Assets (%) | 11.90 | 13.69 | 12.62 | 10.75 | 7.97 |
| Long Term Debt / Equity (X) | 0.00 | 0.01 | 0.01 | 0.00 | 0.06 |
| Total Debt / Equity (X) | 0.88 | 0.61 | 0.93 | 0.99 | 1.05 |
| Asset Turnover Ratio (%) | 1.87 | 1.74 | 1.98 | 2.27 | 2.87 |
| Current Ratio (X) | 1.83 | 1.87 | 1.67 | 1.59 | 1.58 |
| Quick Ratio (X) | 0.15 | 0.16 | 0.13 | 0.36 | 0.39 |
| Inventory Turnover Ratio (X) | 2.14 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 5.78 | 6.44 | 7.34 | 7.51 | 6.95 |
| Interest Coverage Ratio (Post Tax) (X) | 5.30 | 5.86 | 6.54 | 6.55 | 5.44 |
| Enterprise Value (Cr.) | 1360.24 | 2381.64 | 3911.29 | 451.30 | 172.02 |
| EV / Net Operating Revenue (X) | 3.79 | 9.27 | 17.16 | 2.33 | 1.00 |
| EV / EBITDA (X) | 38.30 | 80.90 | 176.14 | 31.71 | 18.93 |
| MarketCap / Net Operating Revenue (X) | 3.54 | 9.09 | 16.93 | 2.13 | 0.85 |
| Price / BV (X) | 12.12 | 29.82 | 68.49 | 10.43 | 5.07 |
| Price / Net Operating Revenue (X) | 3.54 | 9.09 | 16.93 | 2.13 | 0.85 |
| EarningsYield | 0.02 | 0.01 | 0.00 | 0.02 | 0.03 |
After reviewing the key financial ratios for Bombay Super Hybrid Seeds Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 2.52. This value is below the healthy minimum of 5. It has increased from 2.10 (Mar 24) to 2.52, marking an increase of 0.42.
- For Diluted EPS (Rs.), as of Mar 25, the value is 2.52. This value is below the healthy minimum of 5. It has increased from 2.10 (Mar 24) to 2.52, marking an increase of 0.42.
- For Cash EPS (Rs.), as of Mar 25, the value is 2.64. This value is below the healthy minimum of 3. It has increased from 2.25 (Mar 24) to 2.64, marking an increase of 0.39.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 9.98. It has increased from 7.46 (Mar 24) to 9.98, marking an increase of 2.52.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 9.98. It has increased from 7.46 (Mar 24) to 9.98, marking an increase of 2.52.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 34.19. It has increased from 24.48 (Mar 24) to 34.19, marking an increase of 9.71.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 3.38. This value is within the healthy range. It has increased from 2.81 (Mar 24) to 3.38, marking an increase of 0.57.
- For PBIT / Share (Rs.), as of Mar 25, the value is 3.26. This value is within the healthy range. It has increased from 2.68 (Mar 24) to 3.26, marking an increase of 0.58.
- For PBT / Share (Rs.), as of Mar 25, the value is 2.67. This value is within the healthy range. It has increased from 2.24 (Mar 24) to 2.67, marking an increase of 0.43.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 2.52. This value is within the healthy range. It has increased from 2.12 (Mar 24) to 2.52, marking an increase of 0.40.
- For PBDIT Margin (%), as of Mar 25, the value is 9.89. This value is below the healthy minimum of 10. It has decreased from 11.46 (Mar 24) to 9.89, marking a decrease of 1.57.
- For PBIT Margin (%), as of Mar 25, the value is 9.53. This value is below the healthy minimum of 10. It has decreased from 10.93 (Mar 24) to 9.53, marking a decrease of 1.40.
- For PBT Margin (%), as of Mar 25, the value is 7.82. This value is below the healthy minimum of 10. It has decreased from 9.15 (Mar 24) to 7.82, marking a decrease of 1.33.
- For Net Profit Margin (%), as of Mar 25, the value is 7.36. This value is within the healthy range. It has decreased from 8.64 (Mar 24) to 7.36, marking a decrease of 1.28.
- For Return on Networth / Equity (%), as of Mar 25, the value is 25.22. This value is within the healthy range. It has decreased from 28.38 (Mar 24) to 25.22, marking a decrease of 3.16.
- For Return on Capital Employeed (%), as of Mar 25, the value is 32.34. This value is within the healthy range. It has decreased from 35.32 (Mar 24) to 32.34, marking a decrease of 2.98.
- For Return On Assets (%), as of Mar 25, the value is 11.90. This value is within the healthy range. It has decreased from 13.69 (Mar 24) to 11.90, marking a decrease of 1.79.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.88. This value is within the healthy range. It has increased from 0.61 (Mar 24) to 0.88, marking an increase of 0.27.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.87. It has increased from 1.74 (Mar 24) to 1.87, marking an increase of 0.13.
- For Current Ratio (X), as of Mar 25, the value is 1.83. This value is within the healthy range. It has decreased from 1.87 (Mar 24) to 1.83, marking a decrease of 0.04.
- For Quick Ratio (X), as of Mar 25, the value is 0.15. This value is below the healthy minimum of 1. It has decreased from 0.16 (Mar 24) to 0.15, marking a decrease of 0.01.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.14. This value is below the healthy minimum of 4. It has increased from 0.00 (Mar 24) to 2.14, marking an increase of 2.14.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 5.78. This value is within the healthy range. It has decreased from 6.44 (Mar 24) to 5.78, marking a decrease of 0.66.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 5.30. This value is within the healthy range. It has decreased from 5.86 (Mar 24) to 5.30, marking a decrease of 0.56.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,360.24. It has decreased from 2,381.64 (Mar 24) to 1,360.24, marking a decrease of 1,021.40.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.79. This value exceeds the healthy maximum of 3. It has decreased from 9.27 (Mar 24) to 3.79, marking a decrease of 5.48.
- For EV / EBITDA (X), as of Mar 25, the value is 38.30. This value exceeds the healthy maximum of 15. It has decreased from 80.90 (Mar 24) to 38.30, marking a decrease of 42.60.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.54. This value exceeds the healthy maximum of 3. It has decreased from 9.09 (Mar 24) to 3.54, marking a decrease of 5.55.
- For Price / BV (X), as of Mar 25, the value is 12.12. This value exceeds the healthy maximum of 3. It has decreased from 29.82 (Mar 24) to 12.12, marking a decrease of 17.70.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.54. This value exceeds the healthy maximum of 3. It has decreased from 9.09 (Mar 24) to 3.54, marking a decrease of 5.55.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.02, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Bombay Super Hybrid Seeds Ltd:
- Net Profit Margin: 7.36%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 32.34% (Industry Average ROCE: 11.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 25.22% (Industry Average ROE: 12.1%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 5.3
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.15
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 46.6 (Industry average Stock P/E: 27.51)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.88
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 7.36%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Agricultural Products | Shreenathji Industrial Estate, Plot No. 11, National Highway 8-B, Rajkot Dist. Gujarat 360023 | info@bombaysuper.in http://www.bombaysuperseeds.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Arvindkumar Kakadia | Chairman & Managing Director |
| Mr. Kiritkumar Kakadia | Executive Director & CFO |
| Mr. Hemang Baxi | Executive Director |
| Mr. Kishorkumar Kakadia | Executive Director |
| Mr. Jadavjibhai Kakadia | Executive Director |
| Mr. Dharmesh Chotai | Ind. Non-Executive Director |
| Mr. Amit Gadhiya | Ind. Non-Executive Director |
| Mr. Hardik Patel | Ind. Non-Executive Director |
| Mrs. Richa Kaushal Mashru | Ind. Non-Executive Director |
| Mr. Harshil Vasani | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Bombay Super Hybrid Seeds Ltd?
Bombay Super Hybrid Seeds Ltd's intrinsic value (as of 06 November 2025) is 109.29 which is 10.42% lower the current market price of 122.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 1,285 Cr. market cap, FY2025-2026 high/low of 180/116, reserves of ₹94 Cr, and liabilities of 222 Cr.
What is the Market Cap of Bombay Super Hybrid Seeds Ltd?
The Market Cap of Bombay Super Hybrid Seeds Ltd is 1,285 Cr..
What is the current Stock Price of Bombay Super Hybrid Seeds Ltd as on 06 November 2025?
The current stock price of Bombay Super Hybrid Seeds Ltd as on 06 November 2025 is 122.
What is the High / Low of Bombay Super Hybrid Seeds Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Bombay Super Hybrid Seeds Ltd stocks is 180/116.
What is the Stock P/E of Bombay Super Hybrid Seeds Ltd?
The Stock P/E of Bombay Super Hybrid Seeds Ltd is 46.6.
What is the Book Value of Bombay Super Hybrid Seeds Ltd?
The Book Value of Bombay Super Hybrid Seeds Ltd is 9.98.
What is the Dividend Yield of Bombay Super Hybrid Seeds Ltd?
The Dividend Yield of Bombay Super Hybrid Seeds Ltd is 0.00 %.
What is the ROCE of Bombay Super Hybrid Seeds Ltd?
The ROCE of Bombay Super Hybrid Seeds Ltd is 21.2 %.
What is the ROE of Bombay Super Hybrid Seeds Ltd?
The ROE of Bombay Super Hybrid Seeds Ltd is 28.8 %.
What is the Face Value of Bombay Super Hybrid Seeds Ltd?
The Face Value of Bombay Super Hybrid Seeds Ltd is 1.00.